H. Mashhedi

Characterization and Phase 1 Trial of a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19

G. Criner, R. Miller, A. Hotson, 2020, medRxiv.

Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.

G. Hampton, P. Hegde, W. Forrest, 2014, The oncologist.

Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma

G. Hampton, P. Hegde, M. Brauer, 2013, Journal of Translational Medicine.

Implicating insulin in neoplastic growth and metabolism

H. Mashhedi, 2011 .

IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer.

M. Pollak, M. Gottardis, E. Birman, 2011, Endocrine-related cancer.

Metformin abolishes increased tumor 18F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet

A. Aliaga, B. Bedell, M. Pollak, 2011, Cell cycle.

Clinical Results with a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19

G. Criner, J. Janc, Richard A. Miller, 2021, medRxiv.

Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma

Matthew J. Brauer, G. Hampton, P. Hegde, 2013, Journal of Translational Medicine.